🇺🇸 FDA
Pipeline program

Houyanqing Oral Liquid

ZDWY-CMY-Houyanqing OL

Phase 3 small_molecule active

Quick answer

Houyanqing Oral Liquid for Nasopharyngeal Cancinoma (NPC) is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Nasopharyngeal Cancinoma (NPC)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials